Amalgamated Bank’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,190
Closed -$21K 2598
2025
Q4
$21K Buy
5,190
+627
+14% +$2.81K ﹤0.01% 2097
2025
Q3
$16K Hold
4,563
﹤0.01% 2245
2025
Q2
$12K Hold
4,563
﹤0.01% 2372
2025
Q1
$8K Buy
4,563
+1,284
+39% +$3.59K ﹤0.01% 2488
2024
Q4
$5K Hold
3,279
﹤0.01% 2755
2024
Q3
$14K Hold
3,279
﹤0.01% 2295
2024
Q2
$18K Buy
3,279
+307
+10% +$2.45K ﹤0.01% 2176
2024
Q1
$30K Sell
2,972
-5,366
-64% -$40.2K ﹤0.01% 2008
2023
Q4
$34K Sell
8,338
-885
-10% -$3.26K ﹤0.01% 2409
2023
Q3
$36K Hold
9,223
﹤0.01% 2386
2023
Q2
$55K Buy
9,223
+165
+2% +$951 ﹤0.01% 2279
2023
Q1
$30K Sell
9,058
-2,063
-19% -$8.24K ﹤0.01% 2503
2022
Q4
$44K Hold
11,121
﹤0.01% 2481
2022
Q3
$67K Hold
11,121
﹤0.01% 2335
2022
Q2
$72K Sell
11,121
-2,738
-20% -$17.4K ﹤0.01% 2315
2022
Q1
$114K Sell
13,859
-1,121
-7% -$9.06K ﹤0.01% 2142
2021
Q4
$232K Buy
14,980
+458
+3% +$8.83K ﹤0.01% 1927
2021
Q3
$327K Buy
+14,522
New +$305K ﹤0.01% 1808

Other funds holding SANA

Amalgamated Bank's SANA Position: Q1 2026 in Review

Amalgamated Bank sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 5,190 shares — an estimated $21K sold.

Amalgamated Bank first reported a position in SANA in Q3 2021 and held it in 18 quarters. The position peaked at $327K in Q3 2021. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Amalgamated Bank reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 5,190 Sana Biotechnology shares in Q1 2026, an estimated $21K.
  • Amalgamated Bank first reported a position in Sana Biotechnology in Q3 2021 and held it in 18 quarters.
  • Amalgamated Bank's Sana Biotechnology position peaked at $327K in Q3 2021.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.